# An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

> **NCT00402103** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 556 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Amlodipine
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00402103
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 556 (ACTUAL)
- **Last updated:** 2011-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402103, "An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00402103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*